Endoplasmic reticulum chaperone glucose regulated protein 170–Pokemon complexes elicit a robust antitumor immune response in vivo

Abstract Previous evidence suggested that the stress protein grp170 can function as a highly efficient molecular chaperone, binding to large protein substrates and acting as a potent vaccine against specific tumors when purified from the same tumor. In addition, Pokemon can be found in almost all ma...

Full description

Saved in:
Bibliographic Details
Published inImmunobiology (1979) Vol. 217; no. 7; pp. 738 - 742
Main Authors Yuan, Bangqing, Xian, Ronghua, Wu, Xianqu, Jing, Junjie, Chen, Kangning, Liu, Guojun, Zhou, Zhenhua
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier GmbH 01.07.2012
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Previous evidence suggested that the stress protein grp170 can function as a highly efficient molecular chaperone, binding to large protein substrates and acting as a potent vaccine against specific tumors when purified from the same tumor. In addition, Pokemon can be found in almost all malignant tumor cells and is regarded to be a promising candidate for the treatment of tumors. However, the potential of the grp170–Pokemon chaperone complex has not been well described. In the present study, the natural chaperone complex between grp170 and the Pokemon was formed by heat shock, and its immunogenicity was detected by ELISPOT and51 Cr-release assays in vitro and by tumor bearing models in vivo . Our results demonstrated that the grp170–Pokemon chaperone complex could elicit T cell responses as determined by ELISPOT and51 Cr-release assays. In addition, immunized C57BL/6 mice were challenged with subcutaneous (s.c.) injection of Lewis cancer cells to induce primary tumors. Treatment of mice with the grp170–Pokemon chaperone complex also significantly inhibited tumor growth and prolonged the life span of tumor-bearing mice. Our results indicated that the grp170–Pokemon chaperone complex might represent a powerful approach to tumor immunotherapy and have significant potential for clinical application.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0171-2985
1878-3279
DOI:10.1016/j.imbio.2012.01.006